Observational studyBMJ open2026
Multimodal characterisation of skeletal muscle properties in children with and without cerebral palsy using a non-invasive approach: an observational study protocol.
Observational study in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06991725 (Botulinum Neurotoxin for Children With Cerebral Palsy), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Botulinum Neurotoxin for Children With Cerebral Palsy: a Delicate Balance Between Clinical Benefits and Muscular Harm
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionChildren with spastic cerebral palsy (CP) often exhibit significant changes in their skeletal muscles due to altered neural control and atypical mechanical loading. While muscle morphology, in particular muscle size, has been extensively studied, other important properties, such as passive stiffness and muscle composition, remain poorly characterised. Previous studies have typically examined these features in isolation, leaving the interactions among morphology, composition and passive stiffness largely unexplored. This protocol addresses these gaps by providing a comprehensive, multimodal assessment of gastrocnemius muscle properties within a single cohort, which will be systematically compared with control data from typically developing (TD) children. METHODS AND ANALYSIS: This protocol outlines a study to characterise gastrocnemius muscle properties in children with spastic CP and TD peers across different age groups. Muscle size will be measured using three-dimensional freehand ultrasound, composition using quantitative MRI and passive muscle tissue stiffness using shear wave elastography. Additionally, isometric and functional plantar flexion strength will be evaluated through handheld dynamometry and functional strength assessments, respectively. Differences in muscle characteristics between CP and TD children will be assessed, and the relationships among muscle properties will be examined. Exploratory analyses will also evaluate potential associations with isometric and functional plantar flexor strength. This integrated approach will provide a detailed multimodal characterisation of age-related alterations in the gastrocnemius muscle in children with CP. TRIAL REGISTRATION NUMBER: NCT06991725.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.